These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 32962278

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Low-frequency coding variants in CETP and CFB are associated with susceptibility of exudative age-related macular degeneration in the Japanese population.
    Momozawa Y, Akiyama M, Kamatani Y, Arakawa S, Yasuda M, Yoshida S, Oshima Y, Mori R, Tanaka K, Mori K, Inoue S, Terasaki H, Yasuma T, Honda S, Miki A, Inoue M, Fujisawa K, Takahashi K, Yasukawa T, Yanagi Y, Kadonosono K, Sonoda KH, Ishibashi T, Takahashi A, Kubo M.
    Hum Mol Genet; 2016 Nov 15; 25(22):5027-5034. PubMed ID: 28173125
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Aflibercept for exudative AMD with persistent fluid on ranibizumab and/or bevacizumab.
    Cho H, Shah CP, Weber M, Heier JS.
    Br J Ophthalmol; 2013 Aug 15; 97(8):1032-5. PubMed ID: 23766432
    [Abstract] [Full Text] [Related]

  • 26. Tachyphylaxis during treatment of exudative age-related macular degeneration with aflibercept.
    Hara C, Wakabayashi T, Fukushima Y, Sayanagi K, Kawasaki R, Sato S, Sakaguchi H, Nishida K.
    Graefes Arch Clin Exp Ophthalmol; 2019 Nov 15; 257(11):2559-2569. PubMed ID: 31482277
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Association of ARMS2 genotype with bilateral involvement of exudative age-related macular degeneration.
    Tamura H, Tsujikawa A, Yamashiro K, Akagi-Kurashige Y, Nakata I, Nakanishi H, Hayashi H, Ooto S, Otani A, Yoshimura N.
    Am J Ophthalmol; 2012 Sep 15; 154(3):542-548.e1. PubMed ID: 22809783
    [Abstract] [Full Text] [Related]

  • 30. Prevalence and characteristics of pseudodrusen subtypes in advanced age-related macular degeneration.
    Shijo T, Sakurada Y, Yoneyama S, Sugiyama A, Kikushima W, Tanabe N, Iijima H.
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun 15; 255(6):1125-1131. PubMed ID: 28251353
    [Abstract] [Full Text] [Related]

  • 31. Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab.
    Bakall B, Folk JC, Boldt HC, Sohn EH, Stone EM, Russell SR, Mahajan VB.
    Am J Ophthalmol; 2013 Jul 15; 156(1):15-22.e1. PubMed ID: 23706500
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Growth of geographic atrophy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration.
    Caire J, Recalde S, Velazquez-Villoria A, Garcia-Garcia L, Reiter N, Anter J, Fernandez-Robredo P, Alfredo García-Layana, Spanish Multicenter Group on AMD.
    JAMA Ophthalmol; 2014 May 15; 132(5):528-34. PubMed ID: 24557084
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. CHOROIDAL THICKNESS AS A PROGNOSTIC FACTOR OF PHOTODYNAMIC THERAPY WITH AFLIBERCEPT OR RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Sakurada Y, Sugiyama A, Tanabe N, Kikushima W, Kume A, Iijima H.
    Retina; 2017 Oct 15; 37(10):1866-1872. PubMed ID: 28002268
    [Abstract] [Full Text] [Related]

  • 37. Efficacy of intravitreal injection of aflibercept in neovascular age-related macular degeneration with or without choroidal vascular hyperpermeability.
    Hata M, Oishi A, Tsujikawa A, Yamashiro K, Miyake M, Ooto S, Tamura H, Nakanishi H, Takahashi A, Yoshikawa M, Yoshimura N.
    Invest Ophthalmol Vis Sci; 2014 Nov 13; 55(12):7874-80. PubMed ID: 25395483
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor.
    Moon DRC, Lee DK, Kim SH, You YS, Kwon OW.
    Korean J Ophthalmol; 2015 Aug 13; 29(4):226-32. PubMed ID: 26240506
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.